Not yet recruiting NCT07740603
Study of CD38 and CD56 in Chronic Myeloid Leukemia
Chronic Myeloid Leukemia (CML)
Hematology
3,640 trials in this section
Recruiting NCT07321652
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Chronic Lymphocytic Leukemia · Small Lymphocytic Leukemia
Recruiting NCT02872987
GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
Acute Lymphoblastic Leukemia · Leukemia · Non-Hodgkin's Lymphoma
Not yet recruiting NCT07524634
Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis
Amyloid Light-chain Amyloidosis
Recruiting NCT06465953
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) · Myelodysplastic Syndromes (MDS)
Recruiting NCT05554393
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Not yet recruiting NCT07526597
Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
Recruiting NCT07455851
A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma
Relapsed Refractory Multiple Myeloma (RRMM)
Recruiting NCT05849207
Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant
Hematologic Malignancies
Recruiting NCT07504458
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia (APL) · Acute Promyelocytic Leukaemia · Acute Promyelocytic Leukemia With PML-RARA
Recruiting NCT05533775
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Mature B-Cell Non-Hodgkin Lymphoma
Recruiting NCT07012044
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Acute Myeloid Leukemia Post Cytotoxic Therapy · Recurrent Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia
Recruiting NCT06669247
A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma
Relapsed/Refractory Multiple Myeloma
Recruiting NCT06675123
Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma
Recurrent Mantle Cell Lymphoma · Refractory Mantle Cell Lymphoma
Recruiting NCT07319845
A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic Syndromes
Myelodysplastic Syndromes
Not yet recruiting NCT07748364
Glofitamab in B-NHL Using Mid-Therapy Intratumoral Transcriptomics
Relapsed/Refractory Diffuse Large B-cell Lymphoma · Relapsed/Refractory Mantle Cell Lymphoma
Recruiting NCT05927571
A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
Relapsed or Refractory Multiple Myeloma
Recruiting NCT06895538
Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy
Leukemia · MDS · Lymphoma
Recruiting NCT04906096
Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL
Primary Central Nervous System Lymphoma · Non-Hodgkin Lymphoma of Extranodal Site
Enrolling by invitation NCT06773936
Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia · CD19+ Acute Leukemia
Recruiting NCT07104032
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
Relapsed/Refractory Primary Central Nervous System Lymphoma
Not yet recruiting NCT07712588
Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)
Diffuse Large B-Cell Lymphoma (DLBCL)
Recruiting NCT06641648
A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined With Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.
Acute Myeloid Leukemia (AML) · Acute Myeloid Leukemia (AML) Relapse · NK Cell
Recruiting NCT06940791
Tirabrutinib Maintenance Versus Placebo in Patients With Primary CNS Lymphoma in Complete Remission (JCOG2104)
Primary Central Nervous System Lymphoma
Recruiting NCT05583617
A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma
Multiple Myeloma
Not yet recruiting NCT07746245
The Efficacy of CAPCT in Patients With PTCL
Peripheral T-Cell Lymphoma
Recruiting NCT06124157
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Not yet recruiting NCT07748455
HMA-Venetoclax Induction in Newly Diagnosed AML
AML · AML (Acute Myeloid Leukemia)
Recruiting NCT07293403
Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas
Follicular Helper T-Cell Lymphoma · Peripheral T-Cell Lymphoma, Not Otherwise Specified
Recruiting NCT05091424
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Recruiting NCT05554406
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm · Acute Myeloid Leukemia Post Cytotoxic Therapy
Recruiting NCT05334069
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Ann Arbor Stage I Lymphoma
Recruiting NCT03150693
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Recruiting NCT05886036
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
Nodular Lymphocyte Predominant B-Cell Lymphoma · Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma · Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma
Recruiting NCT06084936
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Lymphoma
Recruiting NCT06232044
Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma
Recurrent Multiple Myeloma · Refractory Multiple Myeloma
Recruiting NCT01441089
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Prostate Cancer · Breast Cancer · Lung Cancer
Recruiting NCT02682667
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Multiple Myeloma · Lymphoma, Non-Hodgkin · Leukemia-Lymphoma, Adult T-Cell
Recruiting NCT06665100
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
Hematologic Malignancies · Hematopoietic Stem Cell Transplant (HSCT)
Not yet recruiting NCT07746232
Validating DW-MRI and Fat Fraction in Multiple Myeloma Post-ASCT: The RAC-FAT Study"
Multiple Myeloma (MM)
Recruiting NCT07581002
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia
Not yet recruiting NCT07743476
Quantitative Marrow Imaging, Marrow Reserve, And Clinical Outcomes In Patients Undergoing Radiotherapy For Hematologic And Related Disorders
Quantitative Marrow Imaging · Marrow Reserve · Clinical Outcomes
Recruiting NCT07573111
Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
Acute Leukemia · Myelodysplastic Syndrome
Recruiting NCT06441331
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Somatostatin Receptor Positive · NETs · Lymphoma
Recruiting NCT07384715
First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)
R/R AML · R/R HR-MDS · Acute Myeloid Leukemia
Not yet recruiting NCT07741695
Targeting IRAK4 in Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL)
Recruiting NCT06849713
Zanubrutinib, Obinutuzumab, Sonrotoclax (BOSon) or BGB-16673, Obinutuzumab, Sonrotoclax (DOSon) in TN CLL/SLL
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma (SLL)
Recruiting NCT07221500
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL)
Recruiting NCT01676805
Tissue Collection for Studies of Lymph Cancer
Hodgkin Disease · Lymphoma, Non-Hodgkin · Multiple Myeloma
Recruiting NCT06563895
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Amyloidosis · Amyloid Cardiomyopathy · Transthyretin Amyloidosis
Recruiting NCT06652438
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
Acute Myeloid Leukemia, Adult
Recruiting NCT03739814
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative · Recurrent B Acute Lymphoblastic Leukemia · Refractory B Acute Lymphoblastic Leukemia
Recruiting NCT05170399
Vaccine Responses in Patients With B Cell Malignancies
Lymphoma
Not yet recruiting NCT07743957
Selinexor, Daratumumab, and Dexamethasone (XDd) for Light-Chain Cardiac Amyloidosis
Light-chain Cardiac Amyloidosis
Recruiting NCT06756308
A Study of Enasidenib in People With T-Cell Lymphoma
T-cell Lymphoma
Recruiting NCT06577441
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Myelodysplastic Syndrome
Recruiting NCT06672146
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Recruiting NCT06296368
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
Hematologic Malignancies · Lymphoma · Multiple Myeloma
Recruiting NCT07634653
Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)
Leukemia · Acute Leukemia · Acute Lymphoid Leukemia
Not yet recruiting NCT07742527
A Study to Evaluate the Subcutaneous Belantamab (BCMAb) Formulation Versus Intravenous Belantamab in Participants With Multiple Myeloma While Treated With Standard of Care
Multiple Myeloma
Recruiting NCT06760052
Longitudinal Data Registry of Plasma Cell Dyscrasia
Multiple Myeloma and Other Plasma Cell Neoplasms
Recruiting NCT07638683
A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).
Multiple Myeloma · AL Amyloidosis
Not yet recruiting NCT07742891
ReSeT in ALL 2: A Randomized, Controlled Pilot Trial Testing an Optimized, Multi-component Mobile Health Intervention to Reduce Sedentary Time in Early Adolescents and Young Adults (eAYAs) With ALL During Maintenance Therapy
Acute Lymphoblastic Leukemia (ALL) · Sedentary Behavior / Physical Inactivity · Cardiometabolic Health
Recruiting NCT07478991
Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)
Acute Myeloid Leukemia, Adult
Recruiting NCT06317649
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Enrolling by invitation NCT05697861
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy · Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy · Wild-Type Transthyretin Cardiac Amyloidosis
Not yet recruiting NCT07741968
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8
Recruiting NCT06158841
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Recruiting NCT06790394
Test-retest Study With [18F]FBB in Cardiac Amyloidosis
Cardiac Amyloidosis
Recruiting NCT07029737
A Study to Evaluate Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated Mantle Cell Lymphoma in Spain
Mantle-cell Lymphoma
Recruiting NCT06177067
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia · Relapsed Acute Myeloid Leukemia · Acute Leukemia of Ambiguous Lineage
Recruiting NCT07637578
A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma (MM) · Multiple Myeloma Refractory · Multiple Myeloma in Relapse
Recruiting NCT07743112
A Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly Diagnosed Acute Myeloid Leukemia
Acute Myeloid Leukemia
Recruiting NCT06570447
Glofitamab Combination With Chidamide in Patients With Recurrent/Refractory DLBCL
Diffuse Large B-Cell Lymphoma-Recurrent · Diffuse Large B-Cell Lymphoma-Refractory
Recruiting NCT06823167
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Solid Malignancies · Hematologic Malignancies
Recruiting NCT06960993
Mosaic Trial for Stem Cell Transplant Recipients
Hematologic Malignancy · Stem Cell Transplant · Bone Marrow Transplant
Recruiting NCT07742215
A Study of the Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma (AMMADINA)
Myeloma Multiple
Enrolling by invitation NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Leukemia, Myeloid, Acute · Leukemia, Lymphocytic, Chronic, B-Cell · Lymphoma, Non-Hodgkin
Not yet recruiting NCT07739459
Study of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
Recruiting NCT03011814
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Folliculotropic Mycosis Fungoides · Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma · Recurrent Mycosis Fungoides
Recruiting NCT07342478
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
CLL / SLL · CLL (Chronic Lymphocytic Leukemia) · CLL, Refractory
Recruiting NCT07258511
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Recruiting NCT06500884
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Multiple Myeloma
Recruiting NCT00923507
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Waldenstrom Macroglobulinemia · Lymphoplasmacytic Lymphoma · Monoclonal B-Cell Lymphocytosis
Not yet recruiting NCT07740486
A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and Lenalidomide in Patients With Multiple Myeloma After Stem Cell Transplant Who Still Have Detectable Disease
Multiple Myeloma (MM)
Recruiting NCT07518186
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Enrolling by invitation NCT05669989
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
Plasma Cell Myeloma
Recruiting NCT07069699
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
Burkitt Lymphoma · Double-Expressor Lymphoma · High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements
Not yet recruiting NCT07737418
Dyadic Physical Activity Intervention for Children Undergoing Cancer Treatment
Leukemia · Physical Inactivity
Recruiting NCT07142239
Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome
Antiphospholipid Syndrome
Enrolling by invitation NCT03689595
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
Multiple Myeloma
Recruiting NCT06852222
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Leukemia, Myeloid, Acute
Recruiting NCT06965114
Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia
Hairy Cell Leukemia · Recurrent Hairy Cell Leukemia · Refractory Hairy Cell Leukemia
Not yet recruiting NCT07738887
Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
Recruiting NCT06708897
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
CLL / SLL · CLL (Chronic Lymphocytic Leukemia) · SLL (Small Lymphocytic Lymphoma)
Recruiting NCT06152575
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Multiple Myeloma
Not yet recruiting NCT07738510
Evaluate Ofirnoflast in Adults With Very Low- to Intermediate-risk Myelodysplastic Syndromes Requiring Transfusions
Myelodysplastic Syndromes · Anemia
Recruiting NCT07589634
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma
Recruiting NCT06768489
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma
Multiple Myeloma
Recruiting NCT07266441
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma